Rehearing and Suggestion for Rehearing En Banc Denied November 28, 1995.
CUMMINGS, Circuit Judge.
In early 1992, Baxter Healthcare Corporation ("Baxter") and O.R. Concepts, Inc. ("O.R.") entered into an agreement that obligated Baxter to purchase from O.R. at least $3 million of Thermadrape over a 27-month period. Later that year the president of O.R. and others sold 95% of O.R.'s stock to Vital Signs, Inc. ("Vital Signs"), a competitor of Baxter.
Let's get started

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.